Health economics matters in the nanomaterial world: Cost-effectiveness of utilizing an inhalable antibacterial nanomaterial for the treatment of multidrug-resistant pneumonia

Volume: 66, Pages: 101641 - 101641
Published: Aug 1, 2021
Abstract
Bacterial pathogens rapidly develop resistance to clinically approved antibiotics. Together with the subsiding economic incentives for the development of newer and more effective antibiotic therapies, this threatens to cause a bacterial disease pandemic in the next 30 years. For this reason, timely analyses of various scientific and socioeconomic aspects of alternatives to traditional antibiotic therapies are needed. Here, pharmacoeconomic...
Paper Details
Title
Health economics matters in the nanomaterial world: Cost-effectiveness of utilizing an inhalable antibacterial nanomaterial for the treatment of multidrug-resistant pneumonia
Published Date
Aug 1, 2021
Volume
66
Pages
101641 - 101641
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.